HomeNewsBusinessExplained | How does the Indian Railways collision prevention system Kavach work?

Explained | How does the Indian Railways collision prevention system Kavach work?

Indian Railways plans to install Kavach across 2,000 rail route networks in 2022-23 and over 4,000-5,000 rail route networks every subsequent year. At the moment Kavach has been deployed on over 1,098 route km and 65 trains running under the South Central Railway after successful trial runs.

March 30, 2022 / 20:32 IST
Story continues below Advertisement
Representative image.
Representative image.

In a bid to make rail travel safer, the railway ministry earlier this month introduced an indigenously developed train collision avoidance system called Kavach, which automatically brings a train to a halt when it detects an obstacle on the track.

Indian Railways plans to install Kavach across 2,000 rail route networks in 2022-23 and over 4,000-5,000 rail route networks every subsequent year. At the moment Kavach has been deployed on over 1,098 route km and 65 trains running under the South Central Railway after successful trial runs.

Story continues below Advertisement

What is Kavach?

The railways has been developing its own automatic protection system since 2012, under the name Train Collision Avoidance System (TCAS), which got rechristened Kavach or “armour”.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show